Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 31;25(7):1594.
doi: 10.3390/molecules25071594.

Recent Advances in the Synthesis of Oxazole-Based Molecules via van Leusen Oxazole Synthesis

Affiliations
Review

Recent Advances in the Synthesis of Oxazole-Based Molecules via van Leusen Oxazole Synthesis

Xunan Zheng et al. Molecules. .

Abstract

Oxazole compounds, including one nitrogen atom and one oxygen atom in a five-membered heterocyclic ring, are present in various biological activities. Due to binding with a widespread spectrum of receptors and enzymes easily in biological systems through various non-covalent interactions, oxazole-based molecules are becoming a kind of significant heterocyclic nucleus, which have received attention from researchers globally, leading them to synthesize diverse oxazole derivatives. The van Leusen reaction, based on tosylmethylisocyanides (TosMICs), is one of the most appropriate strategies to prepare oxazole-based medicinal compounds. In this review, we summarize the recent advances of the synthesis of oxazole-containing molecules utilizing the van Leusen oxazole synthesis from 1972, aiming to look for potential oxazole-based medicinal compounds, which are valuable information for drug discovery and synthesis.

Keywords: TosMICs; oxazole; synthesis; van Leusen.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
General van Leusen synthesis base on tosylmethylisocyanides (TosMICs).
Scheme 2
Scheme 2
The first example of van Leusen oxazole synthesis.
Scheme 3
Scheme 3
Mechanism of van Leusen oxazole synthesis.
Scheme 4
Scheme 4
Synthesis of 5-aryloxazoles 31.
Scheme 5
Scheme 5
Synthesis of methylketone 33 via aryl-substituted TosMIC reagent.
Scheme 6
Scheme 6
The reaction of 3/2-formylindoles with TosMIC and 34.
Scheme 7
Scheme 7
The reaction of 3/2-formylindoles with TosMIC and 37.
Scheme 8
Scheme 8
Synthesis of C2- and C3-symmetric oxazole derivatives 41, 43, and 45.
Scheme 9
Scheme 9
A one-pot synthesis of 4,5-disubstituted oxazoles 48 in ionic liquid.
Scheme 10
Scheme 10
Synthesis of naphthoxazoles and fused heterobenzoxazoles 51, trans-5-(2-vinylstyryl)oxazole 53, and 5-(arylethenyl)oxazoles 55.
Scheme 11
Scheme 11
Synthesis of BOxaPy 59.
Scheme 12
Scheme 12
Synthesis of potential anticancer drug TOxaPy 61.
Scheme 13
Scheme 13
Synthesis of potential artificial compound 64.
Scheme 14
Scheme 14
The marine natural product streptochlorin analogue 66.
Scheme 15
Scheme 15
Synthesis of ‘propeller-like’ anticancer biomolecular target 68.
Scheme 16
Scheme 16
Synthesis of flexible tripodal 1,3-oxazoles 70 as molecular scaffolds.
Scheme 17
Scheme 17
A novel modified van Leusen strategy for the synthesis of 73.
Scheme 18
Scheme 18
Synthesis of POPOP structural isomers 76 and 79.
Scheme 19
Scheme 19
Synthesis of 81 by modified van Leusen reaction using green media.
Scheme 20
Scheme 20
Synthesis of C3-symmetric star-shaped molecules 83.
Scheme 21
Scheme 21
Synthesis of heterocyclic systems derivatives 85 and 87 based on TosMIC.
Scheme 22
Scheme 22
Synthesis of ‘head-to-tail’-connected asymmetric pyridyl-oxazoles 93 for anticancer purposes.
Scheme 23
Scheme 23
Synthesis of C5-substituted oxazoles 95, 96, and 97.
Scheme 24
Scheme 24
Synthesis of pyrimidine derivative 99.
Scheme 25
Scheme 25
Synthesis of p- and m-position products 102.
Scheme 26
Scheme 26
Synthesis of 5-(2-tosylquinolin-3-yl)oxazole 104.
Scheme 27
Scheme 27
Synthesis of inhibitor of microbial pathogen 106.

Similar articles

Cited by

References

    1. Zhang H.Z., Zhao Z.L., Zhou C.H. Recent advance in oxazole-based medicinal chemistry. Eur. J. Med. Chem. 2018;144:444–492. doi: 10.1016/j.ejmech.2017.12.044. - DOI - PubMed
    1. Kaur R., Palta K., Kumar M., Bhargava M., Dahiya L. Therapeutic potential of oxazole scaffold: A patent review (2006–2017) Expert Opin. Ther. Pat. 2018;28:783–812. doi: 10.1080/13543776.2018.1526280. - DOI - PubMed
    1. Kakkar S., Narasimhan B. A comprehensive review on biological activities of oxazole derivatives. BMC Chem. 2019;13 doi: 10.1186/s13065-019-0531-9. - DOI - PMC - PubMed
    1. Chiacchio M.A., Lanza G., Chiacchio U., Giofre S.V., Romeo R., Iannazzo D., Legnani L. Oxazole-based compounds as anticancer agents. Curr. Med. Chem. 2019;26:7337–7371. doi: 10.2174/0929867326666181203130402. - DOI - PubMed
    1. Aljaar N., Gujjarappa R., Al-Refai M., Shtaiwi M., Malakar C.C. Overview on recent approaches towards synthesis of 2-keto-annulated oxazole derivatives. J. Heterocycl. Chem. 2019;56:2730–2743. doi: 10.1002/jhet.3673. - DOI

MeSH terms

LinkOut - more resources